1
|
Llwyd O, Fan JL, Müller M. Effect of drug interventions on cerebral hemodynamics in ischemic stroke patients. J Cereb Blood Flow Metab 2022; 42:471-485. [PMID: 34738511 PMCID: PMC8985436 DOI: 10.1177/0271678x211058261] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
The ischemic penumbra is sensitive to alterations in cerebral perfusion. A myriad of drugs are used in acute ischemic stroke (AIS) management, yet their impact on cerebral hemodynamics is poorly understood. As part of the Cerebral Autoregulation Network led INFOMATAS project (Identifying New Targets for Management and Therapy in Acute Stroke), this paper reviews some of the most common drugs a patient with AIS will come across and their potential influence on cerebral hemodynamics with a particular focus being on cerebral autoregulation (CA). We first discuss how compounds that promote clot lysis and prevent clot formation could potentially impact cerebral hemodynamics, before focusing on how the different classes of antihypertensive drugs can influence cerebral hemodynamics. We discuss the different properties of each drug and their potential impact on cerebral perfusion and CA. With emerging interest in CA status of AIS patients, either during or soon after treatment when timely reperfusion and salvageable tissue is at its most critical, the properties of these pharmacological agents may be relevant for modelling cerebral perfusion accuracy and for setting individualised treatment strategies.
Collapse
Affiliation(s)
- Osian Llwyd
- Department of Cardiovascular Sciences, Cerebral Haemodynamics in Ageing and Stroke Medicine Research Group, University of Leicester, Leicester, UK
| | - Jui-Lin Fan
- Manaaki Manawa - The Centre for Heart Research, Department of Physiology, Faculty of Medical & Health Sciences, University of Auckland, Auckland, New Zealand
| | - Martin Müller
- Neurozentrum, Klinik für Neurologie und Neurorehabilitation, Luzerner Kantonsspital, Spitalstrasse, Luzern, Switzerland
| |
Collapse
|
2
|
Carr JMJR, Caldwell HG, Ainslie PN. Cerebral blood flow, cerebrovascular reactivity and their influence on ventilatory sensitivity. Exp Physiol 2021; 106:1425-1448. [PMID: 33932955 DOI: 10.1113/ep089446] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2021] [Accepted: 04/26/2021] [Indexed: 11/08/2022]
Abstract
NEW FINDINGS What is the topic of this review? Cerebrovascular reactivity to CO2 , which is a principal factor in determining ventilatory responses to CO2 through the role reactivity plays in determining cerebral extra- and intracellular pH. What advances does it highlight? Recent animal evidence suggests central chemoreceptor vasculature may demonstrate regionally heterogeneous cerebrovascular reactivity to CO2 , potentially as a protective mechanism against excessive CO2 washout from the central chemoreceptors, thereby allowing ventilation to reflect the systemic acid-base balance needs (respiratory changes in P aC O 2 ) rather than solely the cerebral needs. Ventilation per se does not influence cerebrovascular reactivity independent of changes in P aC O 2 . ABSTRACT Alveolar ventilation and cerebral blood flow are both predominantly regulated by arterial blood gases, especially arterial P C O 2 , and so are intricately entwined. In this review, the fundamental mechanisms underlying cerebrovascular reactivity and central chemoreceptor control of breathing are covered. We discuss the interaction of cerebral blood flow and its reactivity with the control of ventilation and ventilatory responsiveness to changes in P C O 2 , as well as the lack of influence of ventilation itself on cerebrovascular reactivity. We briefly summarize the effects of arterial hypoxaemia on the relationship between ventilatory and cerebrovascular response to both P C O 2 and P O 2 . We then highlight key methodological considerations regarding the interaction of reactivity and ventilatory sensitivity, including the following: regional heterogeneity of cerebrovascular reactivity; a pharmacological approach for the reduction of cerebral blood flow; reactivity assessment techniques; the influence of mean arterial blood pressure; and sex-related differences. Finally, we discuss ventilatory and cerebrovascular control in the context of high altitude and congestive heart failure. Future research directions and pertinent questions of interest are highlighted throughout.
Collapse
Affiliation(s)
- Jay M J R Carr
- Centre for Heart, Lung and Vascular Health, University of British Columbia - Okanagan Campus, British Columbia, Canada
| | - Hannah G Caldwell
- Centre for Heart, Lung and Vascular Health, University of British Columbia - Okanagan Campus, British Columbia, Canada
| | - Philip N Ainslie
- Centre for Heart, Lung and Vascular Health, University of British Columbia - Okanagan Campus, British Columbia, Canada
| |
Collapse
|
3
|
Shoemaker LN, Wilson LC, Lucas SJE, Machado L, Walker RJ, Cotter JD. Indomethacin markedly blunts cerebral perfusion and reactivity, with little cognitive consequence in healthy young and older adults. J Physiol 2020; 599:1097-1113. [DOI: 10.1113/jp280118] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2020] [Accepted: 11/05/2020] [Indexed: 12/11/2022] Open
Affiliation(s)
- L. N. Shoemaker
- School of Physical Education, Sport and Exercise Sciences University of Otago Dunedin New Zealand
| | - L. C. Wilson
- Department of Medicine Otago Medical School ‐ Dunedin Campus University of Otago Dunedin New Zealand
| | - S. J. E. Lucas
- Department of Physiology University of Otago Dunedin New Zealand
- School of Sport, Exercise and Rehabilitation Sciences College of Life and Environmental Sciences University of Birmingham Birmingham UK
- Centre for Human Brain Health University of Birmingham Birmingham UK
| | - L. Machado
- Department of Psychology University of Otago Dunedin New Zealand
| | - R. J. Walker
- Department of Medicine Otago Medical School ‐ Dunedin Campus University of Otago Dunedin New Zealand
| | - J. D. Cotter
- School of Physical Education, Sport and Exercise Sciences University of Otago Dunedin New Zealand
| |
Collapse
|
4
|
Hoiland RL, Fisher JA, Ainslie PN. Regulation of the Cerebral Circulation by Arterial Carbon Dioxide. Compr Physiol 2019; 9:1101-1154. [DOI: 10.1002/cphy.c180021] [Citation(s) in RCA: 101] [Impact Index Per Article: 20.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
|
5
|
Hansen AB, Hoiland RL, Lewis NCS, Tymko MM, Tremblay JC, Stembridge M, Nowak-Flück D, Carter HH, Bailey DM, Ainslie PN. UBC-Nepal expedition: The use of oral antioxidants does not alter cerebrovascular function at sea level or high altitude. Exp Physiol 2018; 103:523-534. [DOI: 10.1113/ep086887] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2018] [Accepted: 02/05/2018] [Indexed: 12/19/2022]
Affiliation(s)
- Alexander B. Hansen
- Centre for Heart, Lung & Vascular Health, School of Health and Exercise Sciences; University of British Columbia, Okanagan Campus; Kelowna BC Canada
| | - Ryan L. Hoiland
- Centre for Heart, Lung & Vascular Health, School of Health and Exercise Sciences; University of British Columbia, Okanagan Campus; Kelowna BC Canada
| | - Nia C. S. Lewis
- Centre for Heart, Lung & Vascular Health, School of Health and Exercise Sciences; University of British Columbia, Okanagan Campus; Kelowna BC Canada
| | - Michael M. Tymko
- Centre for Heart, Lung & Vascular Health, School of Health and Exercise Sciences; University of British Columbia, Okanagan Campus; Kelowna BC Canada
| | - Joshua C. Tremblay
- Cardiovascular Stress Response Laboratory, School of Kinesiology and Health Studies; Queen's University; Kingston ON Canada
| | - Michael Stembridge
- Cardiff Centre for Exercise and Health; Cardiff Metropolitan University; Cardiff UK
| | - Daniela Nowak-Flück
- Centre for Heart, Lung & Vascular Health, School of Health and Exercise Sciences; University of British Columbia, Okanagan Campus; Kelowna BC Canada
| | - Howard H. Carter
- Department of Nutrition, Exercise and Sports; University of Copenhagen; Copenhagen Denmark
| | - Damian M. Bailey
- Neurovascular Research Laboratory, Faculty of Life Sciences and Education; University of South Wales; Newport UK
| | - Philip N. Ainslie
- Centre for Heart, Lung & Vascular Health, School of Health and Exercise Sciences; University of British Columbia, Okanagan Campus; Kelowna BC Canada
| |
Collapse
|
6
|
Beaudin AE, Hartmann SE, Pun M, Poulin MJ. Human cerebral blood flow control during hypoxia: focus on chronic pulmonary obstructive disease and obstructive sleep apnea. J Appl Physiol (1985) 2017; 123:1350-1361. [DOI: 10.1152/japplphysiol.00352.2017] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2017] [Revised: 08/01/2017] [Accepted: 08/07/2017] [Indexed: 01/06/2023] Open
Abstract
The brain is a vital organ that relies on a constant and adequate blood flow to match oxygen and glucose delivery with the local metabolic demands of active neurons. Thus exquisite regulation of cerebral blood flow (CBF) is particularly important under hypoxic conditions to prevent a detrimental decrease in the partial pressure of oxygen within the brain tissues. Cerebrovascular sensitivity to hypoxia, assessed as the change in CBF during a hypoxic challenge, represents the capacity of cerebral vessels to respond to, and compensate for, a reduced oxygen supply, and has been shown to be impaired or blunted in a number of conditions. For instance, this is observed with aging, and in clinical conditions such as untreated obstructive sleep apnea (OSA) and in healthy humans exposed to intermittent hypoxia. This review will 1) provide a brief overview of cerebral blood flow regulation and results of pharmacological intervention studies which we have performed to better elucidate the basic mechanisms of cerebrovascular regulation in humans; and 2) present data from studies in clinical and healthy populations, using a translational physiology approach, to investigate human CBF control during hypoxia. Results from studies in patients with chronic obstructive pulmonary disease and OSA will be presented to identify the effects of the disease processes on cerebrovascular sensitivity to hypoxia. Data emerging from experimental human models of intermittent hypoxia during wakefulness will also be reviewed to highlight the effects of intermittent hypoxia on the brain.
Collapse
Affiliation(s)
- Andrew E. Beaudin
- Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
- Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| | - Sara E. Hartmann
- Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
- Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| | - Matiram Pun
- Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
- Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| | - Marc J. Poulin
- Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
- Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
- Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
- Libin Cardiovascular Institute of Alberta, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; and
- Faculty of Kinesiology, University of Calgary, Calgary, Alberta, Canada
| |
Collapse
|